Therapeutic Focus: <em>Drop</em>ping Some Knowledge - Summary - MDSpire

Therapeutic Focus: <em>Drop</em>ping Some Knowledge

Vizz (aceclidine ophthalmic solution) 1.44%, from Lenz Therapeutics, offers spectacle-free vision and the opportunity to secure patient loyalty.

  • By

  • Julie Greenbaum, editor

  • January 1, 2026

  • 4 min

Share

Objective:

To discuss the impact of Vizz (aceclidine ophthalmic solution) 1.44% on presbyopia treatment and patient satisfaction.

Key Findings:
  • Vizz improves near vision within 30 minutes and lasts up to 10 hours.
  • Patients report increased satisfaction and improved quality of life without reading glasses.
  • Vizz helps maintain contact lens use among presbyopic patients.
Interpretation:

Vizz offers a valuable option for presbyopic patients, enhancing their vision and overall satisfaction while fostering practice growth through referrals.

Limitations:
  • Potential mild side effects such as redness or burning upon instillation.
  • Dimmed vision may occur temporarily.
Conclusion:

Vizz represents a significant advancement in presbyopia treatment, benefiting both patients and eye care practices.

Original Source(s)

Therapeutic Focus: <em>Drop</em>ping Some Knowledge

  • by Julie Greenbaum, editor

  • January 1, 2026

Related Content

Refraction Pearls for the Early Presbyope

Dr. Habibi's clinical and patient counseling suggestions.

CSO Meeting 2026 Highlights Convergence of Innovation and Clinical Practice

More than 300 professionals gathered for three days of innovation, education, and collaboration, highlighting the latest advances in ophthalmic technology and clinical practice

  • May 12, 2026

  • 2 min
Contact Lens Practice Pearls: <br>The Art of Specialty Lens Ordering</br>